MDCXW Medicus Pharma Ltd. - Warrant
$0,33
Harga · Agu 11, 2026
Fundamental per Agu 12, 2026
Rentang 52M
$0–$2
1% of range
Peringkat Analis
—
Target Harga
—
P/E (TTM)
-0.9
ROE
—
Margin Laba Bersih
—
MDCXW Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$0.33
Kapitalisasi Pasar
—
P/E (TTM)
-0.9
EPS (TTM)
$-2.74
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$0 – $3
MDCXW Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
$-2.74
2023-12-31
→
2025-12-31
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
MDCXW
Median Rekan
P/E (TTM)
-0.9
—
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
MDCXW
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
MDCXW
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
MDCXW
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
MDCXW
Median Rekan
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi 11
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $8M | $4M | $193.6K | |
| SG&A Expense | $18M | $8M | $5M | |
| Operating Expenses | $34M | $11M | $5M | |
| Operating Income | $-34M | $-11M | $-5M | |
| Other Non-op | $-1M | $25.4K | $-584.8K | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-47M | $-11M | $-5M | |
| EPS (Basic) | $-2.74 | $-1.16 | $-1.53 | |
| EPS (Diluted) | $-2.74 | $-1.16 | $-1.53 | |
| Shares (Basic) | 17,283,824 | 9,619,184 | 3,479,494 | |
| Shares (Diluted) | 17,283,824 | 9,619,184 | 3,479,494 |
Neraca 15
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $2M | |
| Prepaid Expense | $1M | $1M | $173.7K | |
| Current Assets | $10M | $5M | $2M | |
| Total Assets | $10M | $6M | $2M | |
| Accounts Payable | $3M | $1M | $210.8K | |
| Current Liabilities | $10M | $2M | $781.6K | |
| Capital Leases | $60.1K | $205.9K | $0 | |
| Total Liabilities | $10M | $3M | $781.6K | |
| Common Stock | $57M | $31M | $19M | |
| Paid-in Capital | $7M | $2M | $98.6K | |
| Retained Earnings | $-64M | $-29M | $-18M | |
| AOCI | $10.9K | $0 | · | |
| Stockholders' Equity | $-67.6K | $3M | $1M | |
| Liabilities + Equity | $10M | $6M | $2M | |
| Shares Outstanding | 25,176,303 | 11,816,721 | 8,076,673 |
Arus Kas 7
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $2M | $713.1K | $98.6K | |
| Deferred Tax | $0 | $0 | · | |
| Operating Cash Flow | $-23M | $-10M | $-4M | |
| Investing Cash Flow | $-5M | $0 | · | |
| Stock Issued | $10M | $5M | $0 | |
| Financing Cash Flow | $32M | $13M | $6M | |
| Net Change in Cash | $5M | $2M | · |
Valuasi (TTM) 4
| Metrik | Tren | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $-197.4K | $25.4K | · | |
| Net Income TTM | $-47M | $-11M | · | |
| P/E | -0.9 | · | · | |
| Earnings Yield | -109.6% | · | · |
Laporan Laba Rugi 12
| Metrik | Tren | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $5M | $3M | $2M | $1M | $2M | $1M | |
| SG&A Expense | $7M | $10M | $5 | $5M | $3M | $2M | |
| Operating Expenses | $11M | $23M | $15 | $6M | $5M | $4M | |
| Operating Income | $-11M | $-23M | $-15 | $-6M | $-5M | $-4M | |
| Interest Expense | $205.6K | · | · | $0 | · | · | |
| Other Non-op | $-205.6K | $-394.0K | $-555.0K | $-160.0K | $23.9K | $48.9K | |
| Net Income | $-12M | $-15M | $-21M | $-6M | $-5M | $-4M | |
| EPS (Basic) | $-0.21 | $-0.77 | $-1.12 | $-0.43 | $-0.42 | $-0.27 | |
| EPS (Diluted) | $-0.21 | $-0.77 | $-1.12 | $-0.43 | $-0.42 | $-0.27 | |
| Shares (Basic) | 55,055,225 | -27,872,542 | 18,631,668 | 14,284,261 | 12,240,437 | -16,140,220 | |
| Shares (Diluted) | 55,055,225 | -27,872,542 | 18,631,668 | 14,284,261 | 12,240,437 | -16,140,220 | |
| EBITDA | $-11M | · | $-15 | $-6M | $-5M | · |
Neraca 15
| Metrik | Tren | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $9M | $9M | $10M | $4M | $4M | |
| Prepaid Expense | $2M | $1M | $1M | $1M | $1M | $1M | |
| Current Assets | $17M | $10M | $10M | $11M | $5M | $5M | |
| Total Assets | $27M | $10M | $10M | $12M | $6M | $6M | |
| Accounts Payable | $7M | $3M | $2M | $2M | $2M | $1M | |
| Current Liabilities | $11M | $10M | $11M | $9M | $3M | $2M | |
| Capital Leases | $0 | $60.1K | $95.2K | $141.8K | $174.4K | $205.9K | |
| Total Liabilities | $29M | $10M | $11M | $9M | $4M | $3M | |
| Common Stock | $74M | $57M | $4 | $38M | $33M | $31M | |
| Paid-in Capital | $9M | $7M | $6M | $6M | $3M | $2M | |
| Retained Earnings | $-85M | $-64M | $-5 | $-40M | $-34M | $-29M | |
| AOCI | $61.1K | $10.9K | $10.7K | · | · | $0 | |
| Stockholders' Equity | $-2M | $-67.6K | $-910.1K | $3M | $2M | $3M | |
| Liabilities + Equity | $27M | $10M | $10M | $12M | $6M | $6M | |
| Shares Outstanding | 60,168,044 | 25,176,303 | 20,971,122 | 15,936,266 | 13,417,561 | 11,816,721 |
Arus Kas 6
| Metrik | Tren | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $429.7K | $852.8K | $117.4K | $112.3K | $91.7K | |
| Operating Cash Flow | $-7M | $-7M | $-7M | $-5M | $-4M | $-3M | |
| Investing Cash Flow | · | $0 | · | · | · | $0 | |
| Stock Issued | $0 | $0 | $0 | $6M | · | $0 | |
| Financing Cash Flow | $26M | $7M | $10M | $11M | $4M | $2M | |
| Net Change in Cash | $19M | $43.1K | $-1M | $6M | · | $-1M |
Profitabilitas 5
| Metrik | Tren | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | -0.13% | -15038.7% | · | · | |
| Net Margin | · | · | -180917.3% | · | · | · | |
| EBITDA Margin | · | · | -0.13% | -15038.7% | · | · | |
| ROA | -59.5% | · | -419.7% | · | -180.4% | · | |
| ROE | -1564.6% | · | 4600.6% | · | -475.2% | · |
Likuiditas & Solvabilitas 3
| Metrik | Tren | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.6 | · | 0.9 | 1.3 | 1.5 | · | |
| Quick Ratio | 1.4 | · | 0.8 | 1.1 | 1.2 | · | |
| Interest Coverage | -55.8 | · | · | · | · | · |
Efisiensi 1
| Metrik | Tren | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | · | · |
Valuasi (TTM) 6
| Metrik | Tren | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-48M | · | · | · | · | · | |
| Market Cap | $41M | · | $52M | $40M | · | · | |
| P/E | -0.3 | · | -1.1 | -1.6 | · | · | |
| P/B | -23.2 | · | -57.6 | 12.3 | · | · | |
| P / Tangible Book | · | · | · | 12.3 | · | · | |
| Earnings Yield | -304.6% | · | -88.4% | -61.2% | · | · |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Laporan Laba Rugi
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Laba Bersih | $-47M | $-11M | $-5M |
| EPS Dilusian | $-2.74 | $-1.16 | $-1.53 |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Pemilik institusional (13F) 4 pengaju · $64K total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 0 (-1 vs Kuartal sebelumnya) | 2 (+2 vs Kuartal sebelumnya) | 1 (+1 vs Kuartal sebelumnya) | 0 (0 vs Kuartal sebelumnya) | -60K |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $39.390 | 60.600 | 61,89% | Saham |
| Anson Funds Management LP | $18.923 | 42.400 | 29,73% | Saham |
| Connective Capital Management, LLC | $3.900 | 6.000 | 6,13% | Saham |
| UBS Group AG | $1.432 | 2.203 | 2,25% | Saham |